Cargando…
Serum EA-IgA and d-dimer, but not VCA-IgA, are associated with prognosis in patients with nasopharyngeal carcinoma: a meta-analysis
BACKGROUND: Patients with nasopharyngeal cancer (NPC) differ in prognosis, even at the same stage; therefore, new biomarkers are urgently required to identify early-stage NPC patients at high risk of poor prognosis. Although Epstein–Barr virus (EBV) DNA has been used for prognosis, the value of many...
Autores principales: | Liang, Tianhao, Liu, Weixing, Xie, Junyang, Wang, Yiyan, Chen, Gui, Liao, Wenjing, Song, Lijuan, Zhang, Xiaowen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243822/ https://www.ncbi.nlm.nih.gov/pubmed/34193149 http://dx.doi.org/10.1186/s12935-021-02035-2 |
Ejemplares similares
-
Correlation Analysis of Nasopharyngeal Carcinoma TNM Staging with Serum EA IgA and VCA IgA in EBV and VEGF-C and -D
por: Sun, Ruimei, et al.
Publicado: (2015) -
Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma
por: Yu, Xia, et al.
Publicado: (2020) -
A meta-analysis on the EBV DNA and VCA-IgA in diagnosis of Nasopharyngeal Carcinoma
por: Song, Changxin, et al.
Publicado: (2013) -
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma
por: Xue, Ning, et al.
Publicado: (2020) -
Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution
por: Huang, Yuhua, et al.
Publicado: (2017)